Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Glycogen Storage Disease Type IV

ClinicalTrials.gov lists 4 trials for Glycogen Storage Disease Type IV or a narrower condition beneath it. CENTOGENE GmbH Rostock has the most among industry and government lead sponsors, with 1.

MeSH D006011 Congenital / Hereditary / Neonatal C16 C18
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2 Phase 2 1 Not applicable Not applicable 1 Observational Observational 2 Phase 2 Phase 2 1 Not applicable Not applicable 1 Observational Observational 2

Trials per phase

4 of the 4 trials are tagged with Glycogen Storage Disease Type IV itself; the rest are tagged with a narrower condition beneath it.

Get the Glycogen Storage Disease Type IV report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Glycogen Storage Disease Type IV trials start? (4)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2
  • Not applicable
  • Observational

Top of scale: 1

2009: 1 trials (Phase 2 1) 2015: 1 trials (Observational 1) 2016: 1 trials (Not applicable 1) 2018: 1 trials (Observational 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2018 1
2016 1
2015 1
2009 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 4 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Glycogen Storage Disease Type IV trials in? (3)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2 1
Not applicable 1
Observational 2

How many Glycogen Storage Disease Type IV trials are recruiting? (4)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Completed 1
Withdrawn 1
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Glycogen Storage Disease Type IV trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
CENTOGENE GmbH Rostock 1

Which publications cover Glycogen Storage Disease Type IV? (1)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Natural history study of hepatic glycogen storage disease type IV and comparison to Gbe1ys/ys model. JCI insight 2024 Yes

Prevalence (4)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Glycogen storage disease due to glycogen branching enzyme deficiency Point prevalence Unknown Worldwide Not stated Exact
Glycogen storage disease due to glycogen branching enzyme deficiency Prevalence at birth 1-9 / 1 000 000 Worldwide Not stated Exact
Glycogen storage disease due to glycogen branching enzyme deficiency Point prevalence Unknown Worldwide Not stated Exact
Glycogen storage disease due to glycogen branching enzyme deficiency Prevalence at birth 1-9 / 1 000 000 Worldwide Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Glycogen storage disease due to glycogen branching enzyme deficiency 367 Exact Orphanet Rare Disease Ontology (ORDO)
Glycogen storage disease due to glycogen branching enzyme deficiency 367 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages